The investment seeks to provide an unleveraged long exposure to the performance of the IFED Large-Cap US Equity Index Total Return... Show more
IFED seeks to provide exposure to the IFED Large-Cap US Equity Index Total Return. The index is built around the "Invest with the Fed" methodology, which uses Federal Reserve policy signals to classify the prevailing monetary environment as expansive, restrictive, or indeterminate. Within the 500 largest U.S. exchange-listed stocks that pass liquidity and data screens, the methodology then applies twelve firm-specific fundamental metrics to assign each company a score reflecting its expected positioning under the current regime.
The roughly 75 highest-scoring stocks are selected and weighted by their IFED Score, subject to a 10% single-stock cap and a 40% sector cap. The index rebalances when the Fed-driven monetary regime classification shifts, or after six months of stability. This produces a diversified large-cap blend with a value-oriented tilt rather than a market-cap-weighted megacap profile.
As an ETN, IFED is a senior unsecured debt obligation of UBS rather than a fund holding underlying securities. It does not distribute income, and its total return is expressed through price appreciation. Recent top holdings include GILD, WBD, BMY, MMM, EA, SNOW, CAH, BKNG, DASH, and TTWO, with the top ten representing roughly 29% of the portfolio.
IFED sits at the intersection of two investment themes: monetary-policy sensitivity and factor-based large-cap equity selection. Because the index tilts exposure toward companies scored as best positioned for the current Fed environment, its sector and style composition shifts over time. In a restrictive or indeterminate policy backdrop, the methodology has historically favored companies with stronger balance-sheet characteristics and steadier fundamentals, which helps explain the recurring presence of healthcare, consumer staples, and defensive consumer names among the top holdings.
The broader market environment for large-cap U.S. equities has remained shaped by interest-rate expectations, inflation trends, and the pace of economic growth. For a Fed-responsive strategy such as IFED, the key variable is not the absolute level of rates but whether the monetary regime itself shifts, since that is what triggers a rebalance. This makes the product structurally distinct from both a passive large-cap index tracker and a conventional active fund.
Over the trailing 30 days, IFED has eased by roughly 2%, moving from approximately $46.16 to near $45.11, and has traded within a comparatively narrow band. The trailing quarter has been more turbulent. The ETN spiked to a 52-week high near $55 in mid-July before reverting sharply, and it has since consolidated in the mid-$40s, leaving it well below that peak. With a 52-week range spanning roughly $39 to $55, the recent price action reflects a normalization of a period of pronounced volatility rather than a sustained directional trend.
Part of this behavior is structural. IFED is a small, thinly traded ETN with a limited share count, which can amplify premium and discount moves relative to its indicative value. At the same time, the underlying index's value-tilted large-cap blend means performance is driven less by megacap technology leadership and more by the healthcare, media, and consumer-discretionary names that anchor the portfolio. Sector rotation between growth and value, shifts in rate expectations, and the earnings cycles of major holdings are therefore more influential for IFED than headline index momentum.
Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility measures, AI-generated signals, market trends, price patterns, and customizable filters. It is designed to surface trending securities, breakout candidates, and new trading opportunities more efficiently than manual screening, while allowing users to narrow the universe by industry, sector, and performance characteristics. For investors seeking to identify Fed-sensitive equities or compare thematic exposures, the screener offers a structured way to filter large datasets quickly. Explore the AI Screener to refine your own watchlists and uncover opportunities aligned with your investment process.
Looking ahead, the most important variable for IFED is whether the Federal Reserve's monetary-policy stance shifts enough to trigger an index rebalance, since that would alter the selection and weighting of underlying stocks. Investors should monitor interest-rate expectations, inflation data, and economic-growth indicators as signals of a potential regime change.
Beyond monetary policy, the earnings cycles of major holdings in healthcare, media, and consumer discretionary will drive much of the portfolio's fundamental performance. Structural risks specific to the product also warrant attention: as an ETN, IFED carries unsecured issuer credit risk tied to UBS, and its small asset base and low average daily volume can produce persistent premium or discount distortions relative to indicative value. Regulatory developments affecting exchange-traded notes, competitive dynamics in the thematic equity space, and broader capital-flow trends into factor and policy-sensitive strategies round out the factors likely to shape the product's behavior through 2026. These considerations are informational and do not constitute a forecast of future returns.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
IFED broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 45 similar instances where the stock broke above the upper band. In 36 of the 45 cases the stock fell afterwards. This puts the odds of success at 80%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IFED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for IFED entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 55 cases where IFED's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on IFED as a result. In 72 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for IFED just turned positive on November 06, 2026. Looking at past instances where IFED's MACD turned positive, the stock continued to rise in 38 of 48 cases over the following month. The odds of a continued upward trend are 79%.
IFED moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IFED crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.
Following a +21.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where IFED advanced for three days, in 180 of 221 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Category LargeBlend